{"id":412,"date":"2016-11-18T12:26:33","date_gmt":"2016-11-18T20:26:33","guid":{"rendered":"http:\/\/intercase.org\/?p=412"},"modified":"2016-11-28T11:38:09","modified_gmt":"2016-11-28T19:38:09","slug":"a-model-to-replace-the-commercial-insurance-portion-of-the-aca","status":"publish","type":"post","link":"http:\/\/intercase.org\/?p=412","title":{"rendered":"A model to replace the commercial insurance portion of the ACA"},"content":{"rendered":"<p>In my view, any replacement of the ACA needs to separate the discussion into the three major market segments:\u00a0 Medicare, Medicaid and commercial.\u00a0 Commercial in this context includes not just employer based insurance, but also the individual market(s) that were mostly addressed by the ACA through offerings on the several exchanges.<\/p>\n<p>This post will only address the latter, the commercial segment.<\/p>\n<p>In my view, the key problem with runaway costs in the commercial market is that the market has lost most of the feedbacks related to price signals.\u00a0 The price signals are not related to insurance; they are related to care delivery.\u00a0 More price competition among insurers will have little effect (since insurers only make perhaps 3% on premiums).\u00a0 But innovations on the pricing of care delivery could have a material and beneficial effect on costs.<\/p>\n<p>If we look at the rare subsegments of the commercial market where care is not usually covered by insurance (e.g., infertility, lasik surgery, cosmetic surgery, even dentistry) we see that they market behaves &#8220;normally.&#8221;\u00a0 &#8220;Normal&#8221; in this context means that the products (in this case, service bundles) have prices known in advance, the providers compete on quality metrics that are not established by the government, the products have warranties, and the costs for the products have decreased over the last 20 years, even though quality has improved.<\/p>\n<p>I don&#8217;t know of an insured service that meets the above criteria for &#8220;normal.&#8221;<\/p>\n<p>If we were to devise a plan to restore price signals to the provider marketplace, we would first need to remove insurance as the intermediary for most purchases.\u00a0 How might we accomplish that?\u00a0 The easy answer is to raise deductibles, but that clearly answers only a fragment of the problem.\u00a0 But suppose we implement the following model as a framework for replacement of the commercial segment of the ACA:<\/p>\n<ol>\n<li>Keep all existing ACA plans as valid (although it might make sense to relax the limitations on variances by age group)<\/li>\n<li>Allow sales of very high deductible health plans, VHDHPs (think $20,000 deductible).\u00a0 These would be very inexpensive (likely $1,000 to $2,000 per individual per year).<\/li>\n<li>Request or require plans to offer riders to VHDHPs that cover:\n<ul>\n<li>Primary care<\/li>\n<li>Pharmaceuticals<\/li>\n<\/ul>\n<\/li>\n<li>Allow consumers to contribute to HSAs irrespective of the nature of the health plans they select<\/li>\n<li>Allow consumers with any health plan to borrow money from the federal government at the fed funds rate in any instance where they do not have enough cash (or HSA balance) to cover their deductible for health services.<\/li>\n<li>Limit the repayment of debt to the government to the same cash limit as the ACA (9.5% of income).<\/li>\n<\/ol>\n<p>If payers offer a primary care bundle as a rider to a VHDHP, it would probably cost between $600 and $1200 depending on age bracket.\u00a0\u00a0 The moment that insurers offer such bundles, there would be a cascade of primary care providers offering a service bundle for a lower cost (because they don&#8217;t incur claims adjudication costs, and now would have lower billing costs).\u00a0 Consumers would frequently drop their insurer bundle and buy care directly from their primary care provider.<\/p>\n<p>Most individuals in the country (over 50%) would not incur any care costs other than pharmaceuticals beyond their VHDHP and their primary care bundle (which may or may not have a co-pay).\u00a0 If pharmaceutical costs are high, they could buy that rider from the insurer (or from a PBM since they would likely jump in to bypass insurers).\u00a0 That set of products (insurance + care bundle) would cost about half of the existing ACA plan.\u00a0 Folks would abandon ACA plans once they figure this out.\u00a0 And that would be fast.<\/p>\n<p>But what about the 20-30% of people who don&#8217;t use primary care but use mostly specialty care?\u00a0 Diabetics seeing endocrinologists?\u00a0 Ischemic heart disease patients seeing medical cardiologists?<\/p>\n<p>Many of you recognize that physicians talk to each other.\u00a0 If primary care physicians are billing patients $600 per year for a primary care bundle and NOT incurring insurance billing overhead, it is entirely likely that medical specialists would do the same thing for their patients.\u00a0 This means that primary care physicians would be competing with primary care physicians on the basis of cost and quality.\u00a0 Specialists would be competing with specialists on the basis of cost and quality.\u00a0 Do you suppose a multi-specialty group would offer a bundle for all medical physician services?\u00a0\u00a0\u00a0 Hmmmm.<\/p>\n<p>It would take longer for the facility-based care market to move toward consumer-understandable products.\u00a0 In the interim, acute services that surpass the $20,000 deductible are covered.\u00a0 Costs below $20,000 would be addressed by a combination of HSA balances and by borrowing from the federal government.\u00a0 Incidentally, most of that borrowed money would actually get paid back.<\/p>\n<p>In this framework, no one is worse off than they were with the ACA.\u00a0 Most patients would see their total costs cut about in half.\u00a0 And now we have actual provider-centric price competition.\u00a0 Imagine.<\/p>\n<p>This is a path to move the care delivery market toward true competitive price signals.<\/p>\n<p>I welcome your comments.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In my view, any replacement of the ACA needs to separate the discussion into the three major market segments:\u00a0 Medicare, Medicaid and commercial.\u00a0 Commercial in this context includes not just &hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[6],"tags":[],"_links":{"self":[{"href":"http:\/\/intercase.org\/index.php?rest_route=\/wp\/v2\/posts\/412"}],"collection":[{"href":"http:\/\/intercase.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/intercase.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/intercase.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/intercase.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=412"}],"version-history":[{"count":10,"href":"http:\/\/intercase.org\/index.php?rest_route=\/wp\/v2\/posts\/412\/revisions"}],"predecessor-version":[{"id":424,"href":"http:\/\/intercase.org\/index.php?rest_route=\/wp\/v2\/posts\/412\/revisions\/424"}],"wp:attachment":[{"href":"http:\/\/intercase.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/intercase.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=412"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/intercase.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}